Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omid Cell and Tissue Processing Company is a biotechnology firm specializing in regenerative medicine and tissue engineering. The company focuses on the production of high-quality biological products derived from human tissues, including amniotic membranes, skin substitutes, and bone grafts. Their flagship products are utilized in various clinical applications such as wound care, ophthalmology, and orthopedic surgery. Omid Cell operates advanced processing facilities to ensure the safety and efficacy of its allografts and cell-based therapies. The company plays a significant role in the regional healthcare landscape by providing innovative solutions for complex tissue repair and regeneration.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omid Cell and Tissue Processing.